ClinicalTrials.Veeva

Menu

Angiotensin II Pathway and Postoperative Hypoxemia

Capital Medical University logo

Capital Medical University

Status

Completed

Conditions

Aortic Dissection

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05055570
2021107X

Details and patient eligibility

About

Acute type A aortic dissection is often accompanied by postoperative hypoxemia, the cause of which is not fully understood. Angiotensin II is an important component of the renin-angiotensin system (RAS), which has been suggested to be involved in the development of aortic dissection and pulmonary inflammation.The purpose of this study was to investigate the role and mechanism of angiotensin II pathway in postoperative hypoxemia after acute type A aortic dissection, and to provide reference for clinical application

Enrollment

88 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients undergoing surgery for acute type A aortic dissection
  • age between 18 to 80

Exclusion criteria

  • perioperative severe cardiac insufficiency
  • rejection of consent

Trial design

88 participants in 2 patient groups

Hypoxemia group
Description:
oxygenation index (OI)≤200
Treatment:
Other: No intervention
Non-hypoxemia group
Description:
oxygenation index (OI)\>200
Treatment:
Other: No intervention

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Jun Ma

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems